Terms of Investment | Investor Brief | Technical Appendix | Pilot Program | Pilot Economics | Contact Us
Crown MycoResin Biotech Inc. Opens Investment Opportunities for Myco-Biotechnology in High-Value Resin & Aromatic Crops
Cavite, Philippines — Crown MycoResin Biotech Inc., a biotechnology company focused on advanced myco-resin and fungal–plant interaction technologies, today announced that it is calling for strategic investors and partners to support the scaling and commercialization of its proprietary MycoResin™ biotechnology platform.
Crown MycoResin Biotech Inc. develops science-based solutions that enhance resin formation, secondary metabolite expression, and crop value in premium species such as agarwood (Aquilaria spp.) and other aromatic and perfumery crops. By integrating controlled fungal systems with sustainable cultivation protocols, the company aims to improve yield predictability, resin quality, and time-to-value for plantation and downstream industries.
“Myco-biotechnology represents the next frontier in high-value crop production,” said Manuelito R. Putong, Founder & Chairman of Crown MycoResin Biotech Inc. “Our platform bridges laboratory science and real-world plantations, enabling sustainable, scalable, and commercially viable resin production aligned with global ESG and natural products markets.”
Investment Focus Areas
The investment round will support:
- Scale-up of MycoResin™ fungal–resin induction protocols
- Pilot and commercial plantation deployment
- Research, development, and IP protection
- Lab-to-Land™ technology transfer programs
- Integration with downstream resin, extract, and fragrance value chains
Strategic Market Opportunity
Global demand for oud, natural fragrance ingredients, wellness products, and bio-based aromatics continues to rise, driven by luxury, cultural, and sustainability trends. Crown MycoResin Biotech Inc. positions itself at the intersection of biotechnology, agroforestry, and high-value natural products, offering investors exposure to a defensible, vertically integrable biological asset class.
Ideal Investor and Partner Profile
The company welcomes engagement with:
- Agri-biotech and life science investors
- Natural fragrance, perfumery, and wellness industry partners
- Impact, ESG, and sustainability-focused funds
- Family offices and long-term biological asset investors
- Strategic partners in forestry, extraction, and bio-processing
Next Steps
Qualified investors and partners are invited to request the Investor Brief, Technical Appendix, and Pilot Program Overview, Pilot Economics Snapshot, Go / No-Go Decision Matrix and to participate in site briefings and strategic discussions.
Investment Inquiries:
📧 crownagrigroup.philippines@gmail.com
🌐 www.barinomycochem.com